The invention relates to peptides derived from GLP-1 (Glucagon-like Peptide 1) and exendin-3 and/or exendin-4, which bind to GLP-1 receptors and may be used either marked or unmarked for the production of a means for diagnosis and therapy of benign and pernicious diseases in which GLP-1 receptor expression plays a role.
申请公布号
WO2006024275(A2)
申请公布日期
2006.03.09
申请号
WO2005DE01503
申请日期
2005.08.26
申请人
PHILIPPS-UNIVERSITAET MARBURG;GOTTHARDT, MARTIN;BEHE, MARTIN;BEHR, THOMAS;GOEKE, BURKHARD, J.
发明人
GOTTHARDT, MARTIN;BEHE, MARTIN;BEHR, THOMAS;GOEKE, BURKHARD, J.